Nature Biotechnology: Spotlight on GENEWIZ

South Plainfield, NJ -- December 19, 2012 -- GENEWIZ, Inc., leading global genomic service provider, is featured in this month’s Nature Biotechnology and Nature Reviews Drug Discovery.

Discussing the company’s industry-leading partnership program, GENEWIZ Partnership Solutions (GPS), Dr. Steve Sun, Chairman & CEO, evidenced, "When [customers] send a sample to us, they know when they will get the data back, and they can plan their experiments precisely. If a researcher can save one day a week, that’s 52 days per year. That is an added value we bring to the marketplace." 

Expanding in accordance with market demand, GENEWIZ continues to bolster their service portfolio with the addition of Next Generation Sequencing (NGS) and clinical, CLIA-certified (Clinical Laboratory Improvement Amendments) services, both of which facilitate clinical genomic and diagnostic testing to advance personalized medicine. 

"Genomic advancements over the past ten years have been unprecedented, yet this is just the beginning," said Sun. "At GENEWIZ, we have a well-trained, talented team capable of doing solid science. More importantly, we are committed to providing superior service. This is the DNA of our company, and it defines our future."

The spotlight 'Report on Biotech in China' in the December issues of Nature Biotechnology andNature Reviews Drug Discovery highlights the rising biopharmaceutical clusters and the biopharmaceutical landscape in China, where GENEWIZ has operations in Beijing and Suzhou.

About GENEWIZ, Inc.

GENEWIZ, Inc. is a global contract research organization (CRO) specializing in genomic services, including DNA sequencing, gene synthesis, molecular biology, genomic, bioinformatics, and GxP/CLIA regulatory-compliant services. GENEWIZ leads the industry in outsourcing partnerships with pharmaceutical, biotechnology, clinical, academic, and government institutions.

Headquartered in South Plainfield, NJ, GENEWIZ, Inc. is a privately-held global enterprise with locations in Boston, MA; San Diego, CA; Washington, DC Metro; Research Triangle Park, NC; and Seattle, WA. International locations include Beijing, China; Suzhou, China; and London, United Kingdom.